Hematopoietic stem and progenitor cells: Clinical and preclinical regeneration of the hematolymphoid system

Annual Review of Medicine

Volumn 56, Issue , 2005, Pages 509-538

  Shizuru, Judith A ^a   Negrin, Robert S ^a   Weissman, Irving L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmune; Bone marrow; Cancer; Embryonic stem cell; Transplantation

Indexed keywords

CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR;

AUTOIMMUNE DISEASE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW; CANCER CELL; CELL FATE; CELL ISOLATION; CELL MATURATION; CLINICAL TRIAL; EMBRYONIC STEM CELL; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC SYSTEM; HUMAN; IMMUNOLOGICAL TOLERANCE; LYMPHATIC SYSTEM; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; NONHUMAN; PLASTICITY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; STEM CELL;

ANIMALS; ANTIGENS, CD34; AUTOIMMUNE DISEASES; CELL DIFFERENTIATION; CELL SEPARATION; CELL TRANSFORMATION, NEOPLASTIC; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNE TOLERANCE; LYMPHATIC SYSTEM; MULTIPOTENT STEM CELLS; REGENERATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 14544274561     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.54.101601.152334     Document Type: Review

References (190)

1. Weissman IL. 2000. Stem cells: units of development, units of regeneration, and units in evolution. Cell 100:157-68
2. Weissman IL. 2000. Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science 287:1442-46
3. + cells are the only stem cells in C57BL/Ka-Thy-1.1 bone marrow. J. Exp. Med. 175:175-84
4. Uchida N, Tsukamoto A, He D, et al. 1998. High doses of purified stem cells cause early hematopoietic recovery in syngeneic and allogeneic hosts. J. Clin. Invest. 101:961-66
5. Till JE, McCulloch EA. 1961. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat. Res. 14:1419-30
6. Ezine S, Weissman IL, Rouse RV. 1984. Bone marrow cells give rise to distinct cell clones within the thymus. Nature 309:629-31
7. Muller-Sieburg CE, Whitlock CA, Weissman IL. 1986. Isolation of two early B lymphocyte progenitors from mouse marrow: a committed pre-pre-B cell and a clonogenic Thy-1-lo hematopoietic stem cell. Cell 44:653-62
8. Spangrude GJ, Heimfeld S, Weissman IL. 1988. Purification and characterization of mouse hematopoietic stem cells. Science 241:58-62
9. Baum CM, Weissman IL, Tsukamoto AS, et al. 1992. Isolation of a candidate human hematopoietic stem-cell population. Proc. Natl. Acad. Sci. USA 89:2804-8
10. Ikuta K, Weissman IL. 1992. Evidence that hematopoietic stem cells express mouse c-Kit but do not depend on steel factor for their generation. Proc. Natl. Acad. Sci. USA 89:1502-6
11. Morrison SJ, Wright DE, Weissman IL. 1997. Cyclophosphamide/granulocyte colony-stimulating factor induces hematopoietic stem cells to proliferate prior to mobilization. Proc. Natl. Acad. Sci. USA 94:1908-13
12. Uchida N. 1992. Characterization of mouse hematopoietic stem cells. PhD thesis, Stanford Univ., 304 pp.
13. Osawa M, Hanada K, Hamada H, et al. 1996. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273:242-45
14. Smith LG, Weissman IL, Heimfeld S. 1991. Clonal analysis of hematopoietic stem-cell differentiation in vivo. Proc. Natl. Acad. Sci. USA 88:2788-92
15. Wagers AJ, Sherwood RI, Christensen JL, et al. 2002. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 297:2256-59
16. DiGiusto D, Chen S, Combs J, et al. 1994. Human fetal bone marrow early progenitors for T, B, and myeloid cells are found exclusively in the population expressing high levels of CD34. Blood 84:421-32
17. Bhatia M, Bonnet D, Murdoch B, et al. 1998. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat. Med. 4:1038-45
18. Peled A, Petit I, Kollet O, et al. 1999. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283:845-48
19. + hematopoietic stem cells in patients with metastatic breast cancer. Biol. Blood Marrow Transplant. 6:262-71
20. + hematopoietic stem cells in patients with recurrent indolent non-Hodgkin's lymphoma. Biol. Blood Marrow Transplant. 7:680-87
21. + hematopoietic stem cells (HSC) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitution. Exp. Hematol. 28:858-70
22. Manz MG, Akashi K, Weissman I. 2004. Biology of hematopoietic stem and progenitor cells. In Thomas' Hematopoietic Cell Transplantation, ed. KG Blume, SJ Forman, F Applebaum, pp. 69-95. Malden, MA: Blackwell
23. Morrison SJ, Weissman IL. 1994. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity 1:661-73
24. Christensen JL, Weissman IL. 2001. Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells. Proc. Natl. Acad. Sci. USA 98:14541-46
25. Morrison SJ, Wandycz AM, Hemmati HD, et al. 1997. Identification of a lineage of multipotent hematopoietic progenitors. Development 124:1929-39
26. Kondo M, Weissman IL, Akashi K. 1997. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91:661-72
27. Akashi K, Traver D, Miyamoto T, et al. 2000. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404:193-97
28. Galy A, Travis M, Cen D, et al. 1995. Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity 3:459-73
29. Hao QL, Zhu J, Price MA, et al. 2001. Identification of a novel, human multilymphoid progenitor in cord blood. Blood 97:3683-90
30. Spits H, Blom B, Jaleco AC, et al. 1998. Early stages in the development of human T, natural killer and thymic dendritic cells. Immunol. Rev. 165:75-86
31. +CD3- cells, as well as macrophages. J. Immunol. 166:6593-601
32. Traver D, Miyamoto T, Christensen J, et al. 2001. Fetal liver myelopoiesis occurs through distinct, prospectively isolatable progenitor subsets. Blood 98:627-35
33. Manz MG, Miyamoto T, Akashi K, et al. 2002. Prospective isolation of human clonogenic common myeloid progenitors. Proc. Natl. Acad. Sci. USA 99:11872-77
34. Traver D, Akashi K, Manz M, et al. 2000. Development of CD8alpha-positive dendritic cells from a common myeloid progenitor. Science 290:2152-54
35. Manz MG, Traver D, Miyamoto T, et al. 2001. Dendritic cell potentials of early lymphoid and myeloid progenitors. Blood 97:3333-41
36. Nakorn TN, Miyamoto T, Weissman IL. 2003. Characterization of mouse clonogenic megakaryocyte progenitors. Proc. Natl. Acad. Sci. USA 100:205-10
37. Na Nakorn T, Traver D, Weissman IL, et al. 2002. Myeloerythroid- restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S. J. Clin. Invest. 109:1579-85
38. Domen J, Weissman IL. 2000. Hematopoietic stem cells need two signals to prevent apoptosis; BCL-2 can provide one of these, Kit1/c-Kit signaling the other. J. Exp. Med. 192:1707-18
39. Kondo M, Wagers AJ, Manz MG, et al. 2003. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu. Rev. Immunol. 21:751-806
40. Nusse R, Varmus HE. 1992. Wnt genes. Cell 69:1073-87
41. Cadigan KM, Nusse R. 1997. Wnt signaling: a common theme in animal development. Genes Dev. 11:3286-305
42. Willert K, Brown JD, Danenberg E, et al. 2003. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423:448-52
43. Reya T, Duncan AW, Allies L, et al. 2003. Regulation of hematopoietic stem cells in self-renewal by the Wnt signaling pathway. Nature 423:409-14
44. Reya T, Morrison SJ, Clarke MF, et al. 2001. Stem cells, cancer, and cancer stem cells. Nature 414:105-11
45. Karanu FN, Murdoch B, Gallacher L, et al. 2000. The notch ligand jagged-1 represents a novel growth factor of human hematopoietic stem cells. J. Exp. Med. 192:1365-72
46. Varnum-Finney B, Xu L, Brashem-Stein C, et al. 2000. Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling. Nat. Med. 6:1278-81
47. Kyba M, Perlingeiro RC, Daley GQ. 2002. HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell 109:29-37
48. Antonchuk J, Sauvageau G, Humphries RK. 2002. HOXB4-induced expansion of adult hematopoietic stem cells ex vivo. Cell 109:39-45
49. Antonchuk J, Sauvageau G, Humphries RK. 2001. HOXB4 overexpression mediates very rapid stem cell regeneration and competitive hematopoietic repopulation. Exp. Hematol. 29:1125-34
50. Sauvageau G, Thorsteinsdottir U, Eaves CJ, et al. 1995. Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. Genes Dev. 9:1753-65
51. Park IK, Qian D, Kiel M, et al. 2003. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423:302-5
52. Molofsky AV, Pardal R, Iwashita T, et al. 2003. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 425:962-67
53. Muller-Sieburg CE, Riblet R. 1996. Genetic control of the frequency of hematopoietic stem cells in mice: mapping of a candidate locus to chromosome 1. J. Exp. Med. 183:1141-50
54. de Haan G, Van Zant G. 1997. Intrinsic and extrinsic control of hematopoietic stem cell numbers: mapping of a stem cell gene. J. Exp. Med. 186:529-36
55. Morrison SJ, Qian D, Jerabek L, et al. 2002. A genetic determinant that specifically regulates the frequency of hematopoietic stem cells. J. Immunol. 168:635-42
56. Park IK, He Y, Lin F, et al. 2002. Differential gene expression profiling of adult murine hematopoietic stem cells. Blood 99:488-98
57. Phillips RL, Ernst RE, Brunk B, et al. 2000. The genetic program of hematopoietic stem cells. Science 288:1635-40
58. Terskikh AV, Easterday MC, Li L, et al. 2001. From hematopoiesis to neuropoiesis: evidence of overlapping genetic programs. Proc. Natl. Acad. Sci. USA 98:7934-39
59. Wright DE, Wagers AJ, Gulati AP, et al. 2001. Physiological migration of hematopoietic stem and progenitor cells. Science 294:1933-36
60. Wright DE, Cheshier SH, Wagers AJ, et al. 2001. Cyclophosphamide/ granulocyte colony-stimulating factor causes selective mobilization of bone marrow hematopoietic stem cells into the blood after M phase of the cell cycle. Blood 97:2278-85
61. Goodman J. 1970. Stem cells circulating in the blood. Rev. Eur. Etudes Clin. Biol. 15:149-50
62. Richman CM, Weiner RS, Yankee RA. 1976. Increase in circulating stem cells following chemotherapy in man. Blood 47:1031-39
63. Duhrsen U, Villeval JL, Boyd J, et al. 1988. Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood 72:2074-81
64. Socinski MA, Cannistra SA, Elias A, et al. 1988. Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man. Lancet 1:1194-98
65. Fibbe WE, Pruijt JF, Velders GA, et al. 1999. Biology of IL-8-induced stem cell mobilization. Ann. N.Y. Acad. Sci. 872:71-82
66. + hematopoietic stem cells following mobilization by cyclophosphamide/granulocyte colony-stimulating factor. Exp. Hematol. 30:176-85
67. Wright DE, Bowman EP, Wagers AJ, et al. 2002. Hematopoietic stem cells are uniquely selective in their migratory response to chemokines. J. Exp. Med. 195:1145-54
68. a. Allsopp RC, Morin GB, DePinho R, et al. 2003. Telomerase is required to slow telomere shortening and extend replicative lifespan of HSC during serial transplantation. Blood 102:517-20
69. Domen J, Gandy KL, Weissman EL. 1998. Systemic overexpression of BCL-2 in the hematopoietic system protects transgenic mice from the consequences of lethal irradiation. Blood 91:2272-82
70. Miyamoto T, Iwasaki H, Reizis B, et al. 2002. Myeloid or lymphoid promiscuity as a critical step in hematopoietic lineage commitment. Dev. Cell 3:137-47
71. Moore MA, Metcalf D. 1970. Ontogeny of the haemopoietic system: yolk sac origin of in vivo and in vitro colony forming cells in the developing mouse embryo. Br. J. Haematol. 18:279-96
72. Weissman I, Papaioannou V, Gardner R. 1978. Differentiation of normal and neoplastic hematopoietic cells. In Cold Spring Harbor Meeting on Differentiation of Normal and Neoplastic Hematopoeitic Cells, ed. B Clarkson, PA Marks, JE Till, pp. 33-47. New York: Cold Spring Harbor Lab. Press
73. Akashi K, Weissman EL. 2001. Stem cells and hematolymphoid development. In Hematopoiesis: A Developmental Approach, ed. LI Zon, pp. 15-34. Oxford, UK: Oxford Univ. Press
74. Yoder MC. 2001. Introduction: spatial origin of murine hematopoietic stem cells. Blood 98:3-5
75. Cumano A, Godin I. 2001. Pluripotent hematopoietic stem cell development during embryogenesis. Curr. Opin. Immunol. 13:166-71
76. Ikuta K, Kina T, MacNeil I, et al. 1990. A developmental switch in thymic lymphocyte maturation potential occurs at the level of hematopoietic stem cells. Cell 62:863-74
77. Morrison SJ, Hemmati HD, Wandycz AM, et al. 1995. The purification and characterization of fetal liver hematopoietic stem cells. Proc. Nad. Acad. Sci. USA 92:10302-6
78. Rebel VI, Miller CL, Eaves CJ, et al. 1996. The repopulation potential of fetal liver hematopoietic stem cells in mice exceeds that of their liver adult bone marrow counterparts. Blood 87:3500-7
79. Potocnik AJ, Brakebusch C, Fassler R. 2000. Fetal and adult hematopoietic stem cells require beta1 integrin function for colonizing fetal liver, spleen, and bone marrow. Immunity 12:653-63
80. Hirsch E, Iglesias A, Potocnik AJ, et al. 1996. Impaired migration but not differentiation of haematopoietic stem cells in the absence of betal integrins. Nature 380:171-75
81. Gardner RL. 2001. The initial phase of embryonic patterning in mammals. Int. Rev. Cytol. 203:233-90
82. Keller G, Lacaud G, Robertson S. 1999. Development of the hematopoietic system in the mouse. Exp. Hematol. 27:777-87
83. Balduini CL, Frassoni F, Noris P, et al. 2001. Donor-recipient incompatibility at CD31-codon 563 is a major risk factor for acute graft-versus-host disease after allogeneic bone marrow transplantation from a human leucocyte antigen-matched donor. Br. J. Haematol. 114:951-53
84. Grumet FC, Hiraki DD, Brown BWM, et al. 2001. CD31 mismatching affects marrow transplantation outcome. Biol. Blood Marrow Transplant. 7:503-12
85. Behar E, Chao NJ, Hiraki DD, et al. 1996. Polymorphism of adhesion molecule CD31 and its role in acute graft-versus-host disease. N. Engl. J. Med. 334:286-91
86. Sullivan KM, Agura E, Anasetti C, et al. 1991. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin. Hematol. 28:250-59
87. Socie G, Stone JV, Wingard JR, et al. 1999. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N. Engl. J. Med. 341:14-21
88. Craig W, Kay R, Cutler RL, et al. 1993. Expression of Thy-1 on human hematopoietic progenitor cells. J. Exp. Med. 177:1331-42.
89. +Lin-stem cells in fetal sheep. Exp. Hematol. 24:795-806
90. + hematopoietic stem cells. Blood 83:3758-79
91. +Lin-subpopulation from mobilized peripheral blood. Blood 85:368-78
92. +stem cells do not contain clonal myeloma cells. Blood 86:381-89
93. Ash RC, Casper JT, Chitambar CR, et al. 1990. Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors. N. Engl. J. Med. 322:485-94
94. Kernan NA. 1999. T-cell depletion for the prevention of graft-versus-host disease. In Hematopoietic Cell Transplantation, ed. ED Thomas, KG Blume, SJ Forman, pp. 186-96. Maiden, MA: Blackwell
95. Shizuru JA, Jerabek L, Edwards CT, et al. 1996. Transplantation of purified hematopoietic stem cells: requirements for overcoming the barriers of allogeneic engraftment. Biol. Blood Marrow Transplant. 2:3-14
96. Kumar V, George T, Yu YY, et al. 1997. Role of murine NK cells and their receptors in hybrid resistance. Curr. Opin. Immunol. 9:52-56
97. Yu YY, Kumar V, Bennett M. 1992. Murine natural killer cells and marrow graft rejection. Annu. Rev. Immunol. 10:189-213
98. Roder J, Duwe A. 1979. The beige mutation in the mouse selectively impairs natural killer cell function. Nature 278:451-53
99. Harrison DE, Carlson GA. 1983. Effects of the beige mutation and irradiation on natural resistance to marrow grafts. J. Immunol. 130:484-89
100. Tiberghien P, Longo DL, Wine JW, et al. 1990. Anti-asialo GM1 antiserum treatment of lethally irradiated recipients before bone marrow transplantation: evidence that recipient natural killer depletion enhances survival, engraftment, and hematopoietic recovery. Blood 76:1419-30
101. Lotzova E, Savary CA, Pollack SB. 1983. Prevention of rejection of allogeneic bone marrow transplants by NK 1.1 antiserum. Transplantation 35:490-94
102. Santamaria P, Reinsmoen NL, Lindstrom AL, et al. 1994. Frequent HLA class I and DP sequence mismatches in serologically (HLA-A, HLA-B, HLA-DR) and molecularly (HLA-DRB1, HLA-DQA1, HLA-DQB1) HLA-identical unrelated bone marrow transplant pairs. Blood 83:280-87
103. Petersdorf EW, Hansen JA, Martin PJ, et al. 2001. Major- histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation. N. Engl. J. Med. 345:1794-800
104. Cao TM, Lo B, Ranheim EA, et al. 2003. Variable hematopoietic graft rejection and graft-versus-host disease in MHC-matched strains of mice. Proc. Natl. Acad. Sci. USA 100:11571-76
105. +TCR-cells in whole bone marrow facilitate the engraftment of hematopoietic stem cells across allogeneic barriers. Immunity 11:579-90
106. Kaufman CL, Colson YL, Wren SM, et al. 1994. Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood 84:2436-46
107. Martin PJ. 1993. Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans. J. Exp. Med. 178:703-12
108. Ito M, Shizuru JA. 1999. Graft-vs.-lymphoma effect in an allogeneic hematopoietic stem cell transplantation model. Biol. Blood Marrow Transplant. 5:357-68
109. + NK-T cells in the treatment of lymphoma. Biol. Blood Marrow Transplant. 7:532-42
110. BitMansour A, Burns SM, Traver D, et al. 2002. Myeloid progenitors protect against invasive aspergillosis and Pseudomonas aeruginosa infection following hematopoietic stem cell transplantation. Blood 100:4660-67
111. Arber C, BitMansour A, Sparer TE, et al. 2003. Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantation. Blood 102:421-28
112. Brown JM, Weissman IL, Shizuru JA. 2001. Immunity to infections following hematopoietic cell transplantation. Curr. Opin. Immunol 13:451-57
113. Tyndall A, Koike T. 2002. High-dose immunoablative therapy with hematopoietic stem cell support in the treatment of severe autoimmune disease: current status and future direction. Intern. Med. 41:608-12
114. Burt RK, Slavin S, Burns WH, et al. 2002. Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure? Blood 99:768-84
115. Storb R, Yu C, Sandmaier BM, et al. 1999. Mixed hematopoietic chimerism after marrow allografts. Transplantation in the ambulatory care setting. Ann. N.Y. Acad. Sci. 872:372-75; discussion 5-6
116. Maloney DG, Sandmaier BM, Mackinnon S, et al. 2002. Non-myeloablative transplantation. Hematology (Am. Soc. Hematol. Educ. Program): 392-421
117. Morton JI, Siegel BV. 1974. Transplantation of autoimmune potential. I. Development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand Black mice. Proc. Natl. Acad. Sci. USA 71:2162-65
118. Denman A, Russell A, Denman E. 1969. Adoptive transfer of the diseases of New Zealand Black mice to normal mouse strains. Clin. Exp. Immunol. 5:567-95
119. Morton JI, Siegel BV. 1979. Transplantation of autoimmune potential. IV. Reversal of the NZB autoimmune syndrome by bone marrow transplantation. Transplantation 27:133-34
120. Ikehara S. 2001. Treatment of autoimmune diseases by hematopoietic stem cell transplantation. Exp. Hemat. 29:661-69
121. van Bekkum DW. 2002. Experimental basis of hematopoietic stem cell transplantation for treatment of autoimmune diseases. J. Leuk. Biol. 72:609-20
122. Good RA. 2002. Cellular immunology in a historical perspective. Immunol. Rev. 185:136-58
123. Vyse TJ, Todd JA. 1996. Genetic analysis of autoimmune disease. Cell 85:311-18
124. Wandstrat A, Wakeland E. 2001. The genetics of complex autoimmune diseases: non-MHC susceptibility genes. Nat. Immunol. 2:802-9
125. Beilhack GF, Scheffold YC, Weissman EL, et al. 2003. Purified allogeneic hematopoietic stem cell transplantation blocks diabetes pathogenesis in NOD mice. Diabetes 52:59-68
126. Shultz LD, Sidman CL. 1987. Genetically determined murine models of immunodeficiency. Annu. Rev. Immunol. 5:367-403
127. Marmont AM. 1997. Stem cell transplantation for severe autoimmune disorders, with special reference to rheumatic diseases. J. Rheumatol. Suppl. 48:13-18
128. Wicker LS, Todd JA, Peterson LB. 1995. Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 13:179-200
129. Main JM, Prehn RT. 1955. Successful skin homografts after the administration of high dosage x-irradiation and homologous bone marrow. J. Natl. Cancer Inst. 15:1023-29
130. Billingham RE, Brent L, Medawar PB. 1953. Actively acquired tolerance of foreign cells. Nature 172:603-6
131. McSweeney PA, Storb R. 1999. Mixed chimerism: preclinical studies and clinical applications. Biol. Blood Marrow Transplant. 5:192-203
132. Gandy KL, Weissman EL. 1998. Tolerance of allogeneic heart grafts in mice simultaneously reconstituted with purified allogeneic hematopoietic stem cells. Transplantation 65:295-304
133. Shizuru JA, Weissman EL, Kernoff R, et al. 2000. Purified hematopoietic stem cell grafts induce tolerance to alloantigens and can mediate positive and negative T cell selection. Proc. Natl. Acad. Sci. USA 97:9555-60
134. Shizuru JA, Weissman EL, Kernoff R, et al. 2000. Purified hematopoietic stem cell grafts induce tolerance to alloantigens and can mediate positive and negative T cell selection. Proc. Natl. Acad. Sci. USA 97:9555-60
135. Brazelton TR, Rossi FM, Keshet GI, et al. 2000. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 290:1775-79
136. Mezey E, Chandross KJ, Harta G, et al. 2000. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 290:1779-82
137. Gussoni E, Soneoka Y, Strickland CD, et al. 1999. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401:390-94
138. Ferrari G, Cusella-De Angelis G, Coletta M, et al. 1998. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279:1528-30
139. Bittner RE, Schofer C, Weipoltshammer K, et al. 1999. Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anal. Embryol. 1999:391-96
140. Orlic D, Kajstura J, Chimenti S, et al. 2001. Bone marrow cells regenerate infarcted myocardium. Nature 410:701-5
141. Krause DS, Theise ND, Collector MI, et al. 2001. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105:369-77
142. Jackson KA, Majka SM, Wang H, et al. 2001. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Invest. 107:1395-402
143. Lagasse E, Connors H, Al-Dhalimy M, et al. 2000. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat. Med. 6:1229-34
144. Petersen BE, Bowen WC, Patrene KD, et al. 1999. Bone marrow as a potential source of hepatic oval cells. Science 284:1168-70
145. Thiese ND, Badve S, Saxena R, et al. 2000. Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology 31:234-40
146. Alison MR, Poulsom R, Jeffrey R, et al. 2000. Hepatocytes from non-hepatic adult stem cells. Nature 406:257
147. Shimizu K, Sugiyama S, Aikawa M, et al. 2001. Host bone-marrow cells are a source of donor intimal smooth-muscle-like cells in murine aortic transplant arteriopathy. Nat. Med. 7:738-41
148. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. 2002. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49
149. Gronthos S, Zannettino AC, Hay SJ, et al. 2003. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J. Cell. Sci. 116:1827-35
150. Colter DC, Sekiya I, Prockop DJ. 2001. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc. Natl. Acad. Sci. USA 98:7841-45
151. Ying QL, Nichols J, Evans EP, et al. 2002. Changing potency by spontaneous fusion. Nature 416:545-48
152. Terada N, Hamazaki T, Oka M, et al. 2002. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416:542-45
153. Sherwood RI, Christensen JL, Weissman IL, Wagers AJ. 2004. Determinants of skeletal muscle contributions from circulating cells, bone marrow cells, and hematopoietic stem cells. Stem Cells. In press
154. Balsam LB, Wagers AJ, Christensen JL, et al. 2004. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428:668-73
155. Stemple DL, Anderson DJ. 1992. Isolation of a stem cell for neurons and glia from the mammalian neural crest. Cell 71:973-85
156. Morrison SJ, White PM, Zock C, et al. 1999. Prospective identification, isolation by flow cytometry, and in vivo self-renewal of multipotent mammalian neural crest stem cells. Cell 96:737-49
157. Uchida N, Buck DW, He D, et al. 2000. Direct isolation of human central nervous system stem cells. Proc. Natl Acad. Sci. USA 97:14720-25
158. Martin GR. 1981. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA 78:7634-38
159. Evans MJ, Kaufman MH. 1981. Establishment in culture of pluripotential cells from mouse embryos. Nature 292:154-56
160. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. 1998. Embryonic stem cell lines derived from human blastocysts. Science 282:1145-47
161. Itskovitz-Eldor J, Schuldiner M, Karsenti D, et al. 2000. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol. Med. 6:88-95
162. Kaufman DS, Hanson ER, Lewis RL, et al. 2001. Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc. Natl. Acad. Sci. USA 98:10716-21
163. Dzierzak E, Medvinsky A. 1995. Mouse embryonic hematopoiesis. Trends Genet. 11:359-66
164. Yoder MC, Hiatt K, Mukherjee P. 1997. In vivo repopulating hematopoietic stem cells are present in the murine yolk sac at day 9.0 postcoitus. Proc. Natl. Acad. Sci. USA 94:6776-80
165. Lee SH, Lumelsky N, Studer L, et al. 2001. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292:740-43
166. Brivanlou AH, Gage FH, Jaenisch R, et al. 2003. Stem cells. Setting standards for human embryonic stem cells. Science 300:913-16
167. Rideout WM 3rd, Hochedlinger K, Kyba M, et al. 2002. Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell 109:17-27
168. Hochedlinger K, Jaenisch R. 2002. Monoclonal mice generated by nuclear transfer from mature B and T donor cells. Nature 415:1035-38
169. McCune JM, Namikawar Kaneshima H, et al. 1988. The SCID-hu mouse; murine model for the analysis of human hematolymphoid differentiation and function. Science 241:1632-39
170. Namikawa R, Kaneshima H, Lieberman M, et al. 1988. Infection of the SCID-hu mouse by HIV-1. Science 242:1684-86
171. Weissman IL. 2002. Stem cells-scientific, medical, and political issues. N. Engl J. Med. 346:1576-79
172. Traver D, Akashi K, Weissman IL, et al. 1998. Mice defective in two apoptosis pathways in the myeloid lineage develop acute myeloblastic leukemia. Immunity 9:47-57
173. Chan T, Fischer Lindahl K. 1985. Skin graft rejection caused by the maternally transmitted antigen Mta. Transplantation 39:477-80
174. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100:57-70
175. Jamieson CHM, Passegue E, Weissman IL. 2004. Leukemia and leukemic stem cells. In Neuronal Stem Cells, ed. FH Gage, A Björklund, A Prochiantz, Y Christen, pp. 157-82. Berlin: Springer-Verlag
176. Allsopp RC, Cheshier S, Weissman IL. 2002. Telomerase activation and rejuvenation of telomere length in stimulated T cells derived from serially transplanted hematopoietic stem cells. J. Exp. Med. 196:1427-33
177. Qian F, Vaux DL, Weissman IL. 1994. Expression of the integrin alpha 4 beta 1 on melanoma cells can inhibit the invasive stage of metastasis formation. Cell 77:335-74
178. Qian F, Hanahan D, Weissman IL. 2001. L-selectin can facilitate metastasis to lymph nodes in a transgenic mouse model of carcinogenesis. Proc. Natl. Acad. Sci. USA 98:3976-81
179. Rohrer JW, Vasa K, Lynch RG. 1977. Myeloma cell immunoglobulin expression during in vivo growth in diffusion chambers: evidence for repetitive cycles of differentiation. J. Immunol. 119:861-66
180. Butcher EC, Rouse RV, Coffman RL, et al. 1982. Surface phenotype of Peyer's patch germinal center cells: implications for the role of germinal centers in B cell differentiation. J. Immunol. 129:2698-707
181. Kraal G, Weissman IL, Butcher EC. 1982. Germinal center B cells: antigen specificity and changes in heavy chain class expression. Nature 298:377-79
182. Bonnet D, Dick JE. 1997. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3:730-37
183. Miyamoto T, Weissman IL, Akashi K. 2000. AML1/ETO-expressing non-leukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proc. Natl. Acad. Sci. USA 97:7521-26
184. Blair A, Hogge DE, Ailles LE, et al. 1997. Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo. Blood 89:3104-12
185. Passegue E, Jamieson CHM, Ailles LE, et al. 2003. Normal and leukemic hematopoiesis: Are leukemias a stem cell disorder or a reacquisition of stem cell characteristics? Proc. Natl. Acad. Sci. USA 100:11842-49
186. Jaiswal S, Traver D, Miyamoto T, et al. 2003. Expression of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias. Proc. Natl. Acad. Sci. USA 100:10002-7
187. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. 2003. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100:3983-88
188. Nusse R, Varmus HE. 1982. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 31:99-109
189. Tsukamoto AS, Grosschedl R, Guzman RC, et al. 1988. Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 55:619-25
190. Jamieson CH, Ailles LE, Dylla SJ, et al. 2004. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N. Engl. J. Med. 351:657-67